{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,10]],"date-time":"2024-03-10T00:23:12Z","timestamp":1710030192925},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,9]]},"DOI":"10.7759\/cureus.55858","type":"journal-article","created":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T22:58:45Z","timestamp":1710025125000},"source":"Crossref","is-referenced-by-count":0,"title":["Vancomycin-Induced Neutropenia With Subsequent Perioperative Readministration: A Case Report"],"prefix":"10.7759","author":[{"given":"Yasutaka","family":"Shinoda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teppei","family":"Kawabata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kengo","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiseki","family":"Usami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/zxae014","article-title":"Implementation of vancomycin AUC\/MIC dosing vs traditional trough dosing and incidence of acute kidney injury at a rural community hospital","author":"McClure S","year":"2024","unstructured":"McClure S, McElroy L, Gugkaeva Z. Implementation of vancomycin AUC\/MIC dosing vs traditional trough dosing and incidence of acute kidney injury at a rural community hospital. Am J Health Syst Pharm. 2024, 10.1093\/ajhp\/zxae014","journal-title":"Am J Health Syst Pharm"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2015.04.013","article-title":"Vancomycin-associated nephrotoxicity: a meta-analysis of administration by continuous versus intermittent infusion","volume":"46","author":"Hanrahan T","year":"2015","unstructured":"Hanrahan T, Whitehouse T, Lipman J, Roberts JA. Vancomycin-associated nephrotoxicity: a meta-analysis of administration by continuous versus intermittent infusion. Int J Antimicrob Agents. 2015, 46:249-53. 10.1016\/j.ijantimicag.2015.04.013","journal-title":"Int J Antimicrob Agents"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1P583","article-title":"Vancomycin-induced neutropenia: is it dose- or duration-related?","volume":"45","author":"Black E","year":"2011","unstructured":"Black E, Lau TT, Ensom MH. Vancomycin-induced neutropenia: is it dose- or duration-related?. Ann Pharmacother. 2011, 45:629-38. 10.1345\/aph.1P583","journal-title":"Ann Pharmacother"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.15170","article-title":"Acute antibiotically induced neutropenia: a systematic review of case reports","volume":"88","author":"Holz JM","year":"2022","unstructured":"Holz JM, Chevtchenko AV, Aitullina A. Acute antibiotically induced neutropenia: a systematic review of case reports. Br J Clin Pharmacol. 2022, 88:1978-84. 10.1111\/bcp.15170","journal-title":"Br J Clin Pharmacol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/s0163-4453(05)80002-7","article-title":"High incidence of vancomycin-associated leucopenia and neutropenia in a cardiothoracic surgical unit","volume":"22","author":"Morris A","year":"1991","unstructured":"Morris A, Ward C. High incidence of vancomycin-associated leucopenia and neutropenia in a cardiothoracic surgical unit. J Infect. 1991, 22:217-23. 10.1016\/s0163-4453(05)80002-7","journal-title":"J Infect"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1H633","article-title":"Glycopeptide-induced neutropenia: cross-reactivity between vancomycin and teicoplanin","volume":"41","author":"Hsiao SH","year":"2007","unstructured":"Hsiao SH, Chang CM, Tsai JC, Lin CY, Liao LH, Lin WL, Wu TJ. Glycopeptide-induced neutropenia: cross-reactivity between vancomycin and teicoplanin. Ann Pharmacother. 2007, 41:891-4. 10.1345\/aph.1H633","journal-title":"Ann Pharmacother"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1592\/phco.22.9.783.34059","article-title":"Vancomycin-induced neutropenia in a patient positive for an antineutrophil antibody","volume":"22","author":"Schwartz MD","year":"2002","unstructured":"Schwartz MD. Vancomycin-induced neutropenia in a patient positive for an antineutrophil antibody. Pharmacotherapy. 2002, 22:783-8. 10.1592\/phco.22.9.783.34059","journal-title":"Pharmacotherapy"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1G436","article-title":"Epidemiology of vancomycin-induced neutropenia in patients receiving home intravenous infusion therapy","volume":"40","author":"Pai MP","year":"2006","unstructured":"Pai MP, Mercier RC, Koster SA. Epidemiology of vancomycin-induced neutropenia in patients receiving home intravenous infusion therapy. Ann Pharmacother. 2006, 40:224-8. 10.1345\/aph.1G436","journal-title":"Ann Pharmacother"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.909956","article-title":"Agranulocytosis induced by vancomycin. Case report and literature review","volume":"19","author":"Di Fonzo H","year":"2018","unstructured":"Di Fonzo H, Villegas Gutsch M, Castroagudin A, Cabrera MV, Mazzei ME, Rueda D. Agranulocytosis induced by vancomycin. Case report and literature review. Am J Case Rep. 2018, 19:1053-6. 10.12659\/AJCR.909956","journal-title":"Am J Case Rep"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1E187","article-title":"Probable vancomycin-induced neutropenia","volume":"38","author":"Segarra-Newnham M","year":"2004","unstructured":"Segarra-Newnham M, Tagoff SS. Probable vancomycin-induced neutropenia. Ann Pharmacother. 2004, 38:1855-9. 10.1345\/aph.1E187","journal-title":"Ann Pharmacother"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa475","article-title":"What is the primary driver of preoperative vancomycin use? It's not methicillin-resistant Staphylococcus aureus or allergy","volume":"71","author":"Strymish JM","year":"2020","unstructured":"Strymish JM, O' Brien W, Itani K, Gupta K, Branch-Elliman W. What is the primary driver of preoperative vancomycin use? It's not methicillin-resistant Staphylococcus aureus or allergy. Clin Infect Dis. 2020, 71:2732-5. 10.1093\/cid\/ciaa475","journal-title":"Clin Infect Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-021-05858-6","article-title":"The monitoring of vancomycin: a systematic review and meta-analyses of area under the concentration-time curve-guided dosing and trough-guided dosing","volume":"21","author":"Tsutsuura M","year":"2021","unstructured":"Tsutsuura M, Moriyama H, Kojima N, et al.. The monitoring of vancomycin: a systematic review and meta-analyses of area under the concentration-time curve-guided dosing and trough-guided dosing. BMC Infect Dis. 2021, 21:10.1186\/s12879-021-05858-6","journal-title":"BMC Infect Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo CA","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, et al.. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981, 30:239-45. 10.1038\/clpt.1981.154","journal-title":"Clin Pharmacol Ther"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2009.09.010","article-title":"Tolerability of teicoplanin in 117 hospitalized adults with previous vancomycin-induced fever, rash, or neutropenia: a retrospective chart review","volume":"31","author":"Hung YP","year":"2009","unstructured":"Hung YP, Lee NY, Chang CM, et al.. Tolerability of teicoplanin in 117 hospitalized adults with previous vancomycin-induced fever, rash, or neutropenia: a retrospective chart review. Clin Ther. 2009, 31:1977-86. 10.1016\/j.clinthera.2009.09.010","journal-title":"Clin Ther"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1089\/sur.2013.9999","article-title":"Clinical practice guidelines for antimicrobial prophylaxis in surgery","volume":"14","author":"Bratzler DW","year":"2013","unstructured":"Bratzler DW, Dellinger EP, Olsen KM, et al.. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Surg Infect (Larchmt). 2013, 14:73-156. 10.1089\/sur.2013.9999","journal-title":"Surg Infect (Larchmt)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1Q467","article-title":"Severe neutropenia following a prolonged course of vancomycin that progressed to agranulocytosis with drug reexposure","volume":"46","author":"Duff JM","year":"2012","unstructured":"Duff JM, Moreb JS, Muwalla F. Severe neutropenia following a prolonged course of vancomycin that progressed to agranulocytosis with drug reexposure. Ann Pharmacother. 2012, 46:10.1345\/aph.1Q467","journal-title":"Ann Pharmacother"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1177\/106002808602001010","article-title":"Vancomycin-induced neutropenia","volume":"20","author":"Koo KB","year":"1986","unstructured":"Koo KB, Bachand RL, Chow AW. Vancomycin-induced neutropenia. Drug Intell Clin Pharm. 1986, 20:780-2. 10.1177\/106002808602001010","journal-title":"Drug Intell Clin Pharm"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(78)90915-7","article-title":"Drug-induced immunological neutropenia","volume":"20","author":"Weitzman SA","year":"1978","unstructured":"Weitzman SA, Stossel TP. Drug-induced immunological neutropenia. Lancet. 1978, 20:1068-72. 10.1016\/s0140-6736(78)90915-7","journal-title":"Lancet"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofv007","article-title":"Cephalosporin side chain idiosyncrasies: a case report of ceftriaxone-induced agranulocytosis and review of literature","volume":"2","author":"Uy N","year":"2015","unstructured":"Uy N, Thiagarajan P, Musher DM. Cephalosporin side chain idiosyncrasies: a case report of ceftriaxone-induced agranulocytosis and review of literature. Open Forum Infect Dis. 2015, 2:10.1093\/ofid\/ofv007","journal-title":"Open Forum Infect Dis"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.2147\/CPAA.S406139","article-title":"Cefepime-induced neutropenia: a case report and literature review","volume":"15","author":"Koraysh S","year":"2023","unstructured":"Koraysh S, Koleri J, Ali M. Cefepime-induced neutropenia: a case report and literature review. Clin Pharmacol. 2023, 15:33-40. 10.2147\/CPAA.S406139","journal-title":"Clin Pharmacol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/234431-vancomycin-induced-neutropenia-with-subsequent-perioperative-readministration-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T22:58:49Z","timestamp":1710025129000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/234431-vancomycin-induced-neutropenia-with-subsequent-perioperative-readministration-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,9]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.55858","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3,9]]}}}